The Latest Cardiac and Vascular News
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA) application for its HeartStart OnSite defibrillator [1] and HeartStart Home defibrillator [2], […]
Stellarex is the only low-dose [1] drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years ILLUMENATE Pivotal trial showcases durable primary patency (maintained blood flow) in the most complex patient pool studied in a DCB randomized clinical trial No significant difference in mortality […]
Integrating best-in-class physiology, imaging and co-registration tools across the interventional lab workflow supports physicians in providing cardiac and peripheral vascular patients with superior care Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the new IntraSight interventional applications platform. The secure, application-based […]
May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software, and services to support cryoablation procedures performed with the Medtronic Arctic Front Advance™ cryoablation technology Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance […]
CORAL GABLES, Fla. – Miami Cardiac & Vascular Institute, the largest and most comprehensive cardiovascular center in the South Florida region, is the first in the United States to use technology it developed, in partnership with Philips, that makes it easier for doctors to perform image guided procedures for heart […]
AMSTERDAM, Feb. 18, 2019 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Zenition, its new mobile C-arm imaging platform. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including […]
AMSTERDAM and ORLANDO, Fla., Feb. 13, 2019 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and information management system. The latest version builds on the existing pediatric reporting capabilities, recognizing the important and unique nature of the pediatric environment. Clinicians can now […]
AMSTERDAM and DALLAS, Jan. 23, 2019 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the American Heart Association, the world’s leading voluntary health organization devoted to a world of longer, healthier lives, today announced a collaboration to increase sudden cardiac arrest (SCA) survival rates in densely populated cities around the world. […]
AMSTERDAM, Nov. 12, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first U.S. patient in the Stellarex ILLUMENATE Below-the-Knee (BTK) Investigational Device Exemption (IDE) study, led by principal investigators Dr. Bill Gray and Dr. Mahmood K. Razavi. This unique global, prospective, randomized, multi-center trial is designed […]
AMSTERDAM and MUNICH, Aug. 28, 2018 /PRNewswire/ — Royal Philips (NYSE : PHG , AEX: PHIA), a global leader in health technology, today announced that the European Society of Cardiology has incorporated instantaneous wave-free ratio (iFR) into its updated revascularization guidelines. The new guidelines have provided the highest recommendation (class I A) for iFR alongside fractional flow reserve (FFR) […]
